Immunogenicity of Extracellular Vesicles

© 2024 The Author(s). Advanced Materials published by Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 33 vom: 26. Aug., Seite e2403199
1. Verfasser: Xia, Yutian (VerfasserIn)
Weitere Verfasser: Zhang, Jianzhong, Liu, Gang, Wolfram, Joy
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Review ectosomes exosomes immune responses nanomedicine vesicles
LEADER 01000caa a22002652 4500
001 NLM374205477
003 DE-627
005 20240815232407.0
007 cr uuu---uuuuu
008 240627s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202403199  |2 doi 
028 5 2 |a pubmed24n1502.xml 
035 |a (DE-627)NLM374205477 
035 |a (NLM)38932653 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Xia, Yutian  |e verfasserin  |4 aut 
245 1 0 |a Immunogenicity of Extracellular Vesicles 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 15.08.2024 
500 |a Date Revised 15.08.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2024 The Author(s). Advanced Materials published by Wiley‐VCH GmbH. 
520 |a Extracellular vesicles (EVs) are promising next-generation therapeutics and drug delivery systems due to demonstrated safety and efficacy in preclinical models and early-stage clinical trials. There is an urgent need to address the immunogenicity of EVs (beyond the apparent lack of immunotoxicity) to advance clinical development. To date, few studies have assessed unintended immunological recognition of EVs. An in-depth understanding of EV-induced immunogenicity and clearance is necessary to develop effective therapeutic strategies, including approaches to mitigate immunological recognition when undesired. This article summarizes various factors involved in the potential immunogenicity of EVs and strategies to reduce immunological recognition for improved therapeutic benefit 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a ectosomes 
650 4 |a exosomes 
650 4 |a immune responses 
650 4 |a nanomedicine 
650 4 |a vesicles 
700 1 |a Zhang, Jianzhong  |e verfasserin  |4 aut 
700 1 |a Liu, Gang  |e verfasserin  |4 aut 
700 1 |a Wolfram, Joy  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 33 vom: 26. Aug., Seite e2403199  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:36  |g year:2024  |g number:33  |g day:26  |g month:08  |g pages:e2403199 
856 4 0 |u http://dx.doi.org/10.1002/adma.202403199  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 33  |b 26  |c 08  |h e2403199